ArticleMedicine2026
Simultaneous transcatheter aortic and mitral valve-in-valve replacement: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleThere are fewer reports in China about re-performing combined transcatheter transcatheter aortic and mitral valve-in-valve replacement after bioprosthetic valve failure. Due to the higher difficulty of the combined secondary bivalve procedure and the greater risk of pericardial tamponade and malignant arrhythmias, the professional demands on the surgeon and team are extremely high. It is particularly important to provide quality perioperative care for such patients. PATIENT CONCERNS: This study reports a case of bioprosthetic valve failure after undergoing transcatheter aortic and mitral bicuspid valve-in-valve replacement.After active treatment and careful care, the patient recovered well after the operation and had a good quality of life during the 1 year follow-up period. DIAGNOSES: Valve function was measured by 3-dimensional echocardiography.
interventionsThe key points of perioperative care include: close monitoring of the patient's condition and provision of first aid before surgery; close monitoring of hemodynamic parameters, management of fluid balance, provision of respiratory support and oxygen therapy management, prevention of complications and early cardiac rehabilitation after surgery. OUTCOMES: On the 16th day after the operation, the 3-dimensional echocardiogram showed that the mitral regurgitation was slight. Mitral regurgitation was slight, and aortic valve flow velocity and differential pressure were normalized. At 1 year follow-up, there were no adverse cardiovascular events and quality of life improved. LESSONS: For patients undergoing simultaneous transcatheter bivalve replacement with multiple comorbidities, focus should be placed on constructing an integrated perioperative intervention pathway to comprehensively improve clinical tolerance and control the risk of complex cases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.